Abstract:Cardiac glycosides are group of natural products found to be effective against various cancers. The aim of this study is to propose a binding mode for different conformation of cardiac glycoside analogues to Na+, K+ - ATPase pump which is an important target for various cancer cell lines. Quantitative structure activity relationships model were developed with the cytotoxic activity (Expt. IC50) of 19 compounds based on molecular descriptors like docking score, binding free energy, ADME properties, eMBRAcE solvation model, and pharmacophore based 3D QSAR. In the cases of docking score and binding free energy, the correlation coefficient (R2) was in the range of 0.65–0.98 indicating good data fit, cross validation coefficient (q2) in the range of 0.64-0.99 and RMSE was in the range of 0.00–0.36 indicating that the predictive capabilities of the models were acceptable. The prediction model developed for the 226 conformers using docking score and binding free energy showed R2 in the range of 0.70-0.71, q2 in the range of 0.69-0.71 and RMSE in the range of 0.22-0.28 indicating acceptable prediction capabilities. In addition, a linear correlation was observed between the predicted and experimented pIC50 based on ADME properties with R2 of 0.88, and q2 of 0.73 and RMSE = 0.32. The prediction model developed for 226 conformers using ADME properties indicated a better fit with R2=0.99, q2= 0.99 and RMSE = 0.28. Further the prediction model developed using liaison showed, R2=0.90, q2=0.86, and RMSE=0.23; R2=0.59, q2=0.34 and RMSE= 0.45 for original and conformers respectively showing good to non linear response. The prediction model developed using eMBRAcE showed R2= 0.82, q2= 0.79 and RMSE= 0.28; R2= 0.89, q2= 0.89 and RMSE= 0.20 for original and conformers justify the solvation model parameters are good to use. Finally all the models were validate by pharmacophore based 3D QSAR model for the 19 cardiac glycosides in which the best hypothesis generated correlation coefficient, R2 =0.9733 which is acceptable pharmacophore features . Low level of RMSE and significant R2 and q2 values between Expt. IC50 and Predicted IC50 revealed that the best quality fit based upon all above said approach.

Monte Carlo Method Based QSAR Studies of Mer Kinase Inhibitors in Compliance with OECD Principles

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

3D-QSAR modeling and molecular docking studies on a series of 2, 4, 5-trisubstituted imidazole derivatives as CK2 inhibitors

Improved QSAR models for PARP-1 inhibition using data balancing, interpretable machine learning, and matched molecular pair analysis

Nucleobase sequence based building up of reliable QSAR models with the index of ideality correlation using Monte Carlo method

QSAR study of tetrahydropteridin derivatives as polo-like kinase 1(PLK1) Inhibitors with molecular docking and dynamics study

Hansch-Type QSAR Models for the Rational Design of MAO Inhibitors: Basic Principles and Methodology

Quantitative Structure–Activity Relationship Evaluation of MDA-MB-231 Cell Anti-Proliferative Leads

Machine Learning-Based QSAR Modeling, Molecular Docking, Dynamics Simulation Studies for Cytotoxicity Prediction in MDA-MB231 Triple-Negative Breast Cancer Cell Line

Validating ADME QSAR Models Using Marketed Drugs

2D-QSAR, docking, molecular dynamics, studies of PF-07321332 analogues to identify alternative inhibitors against 3CLpro enzyme in SARS-CoV disease

Theoretical investigation on QSAR of (2-Methyl-3-biphenylyl) methanol analogs as PD-L1 inhibitor

In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies

2D-QSAR modeling, drug-likeness studies, ADMET prediction, and molecular docking for anti-lung cancer activity of 3-substituted-5-(phenylamino) indolone derivatives

QSAR and QSAAR modeling of nitroimidazole sulfonamide radiosensitizers: application of small dataset modeling

The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors

Statistical Evaluation of Cancer Drugs by QSPR Modeling

QSAR-Co: An Open Source Software for Developing Robust Multitasking or Multitarget Classification-Based QSAR Models

QSAR Studies of Sulfonamide Hydroxamates Derivatives as MMP-2 Inhibitors Topomer CoMFA and Molecular Docking

Quantitative structure activity relationship (QSAR) of cardiac glycosides: the development of predictive in vitro cytotoxic activity model

Design and Optimization of Quinazoline Derivatives as Potent EGFR Inhibitors for Lung Cancer Treatment: A Comprehensive QSAR, ADMET, and Molecular Modeling Investigation